Can a Medical Giant Transform Into a Growth Story?Medtronic has demonstrated significant momentum entering 2026, with its recent 23% share price appreciation reflecting fundamental improvements rather than speculative enthusiasm. The company delivered strong fiscal Q2 2026 results with revenue reaching approximately $9 billion, up 6.6% year-over-ye
Medtronic Public Limited Company Cert Deposito Arg Repr 0.25 Shs
No trades
Key facts today
Medtronic's MiniMed Group has filed for an IPO with the SEC to become an independent company focused on diabetes tech, but share details and pricing are not yet revealed.
Proceeds from an upcoming IPO, underwritten by major financial institutions including Goldman Sachs and Morgan Stanley, are intended to repay debt owed to Medtronic.
1,100 ARS
4.62 T ARS
33.21 T ARS
About Medtronic plc.
Sector
Industry
CEO
Geoffrey Straub Martha
Website
Headquarters
Galway
Founded
2014
Identifiers
2
ISINARDEUT111283
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Related stocks
MDT | Monster Rally Incoming!!! | LONGMedtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes
MDT Earnings Explosion – 95C Call for Big Gains!
# 💉 MDT Earnings Call Option – 95C Play (8/21 BMO)
📊 **Market Snapshot**
* Revenue Growth: +3.9% TTM
* Margins: Profit 13.9%, Operating 17.1%, Gross 65.4%
* Earnings Beat History: 100% past 8 quarters ✅
* Forward EPS: \$5.85 → ambitious 62% growth expectation
* Technical Support/Resistance: \$92
Chartamentals (Charting + Fundamentals) : #MDTPrice-to-Earnings (P/E): 16.33; Trailing P/E is moderate, below medical device industry average (20–25).
Price-to-Operating Cash Flow: ~10–12 (estimated); Not explicitly provided, reasonable for strong cash flow generation.
Strategic Advantage: Global leader in heart devices, spinal products, insuli
Medtronic Stock Chart Fibonacci Analysis 042925Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 83.2/61.80%
Chart time frame:B
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress: A
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) 61.80% support
D) Hit the bottom
MedTronic - What is your Opinion? Shall we discuss it?This time as an experiment, why don't we discuss the prospects before taking action-
HERE IS MY CONTRIBUTION - can we all collaborate ?
What Medtronic is doing right:
It looks like these guys make transplant patients nervouse, nervous to have their pace makers hacked. That has t increase liability
Medtronic breaking outNYSE:MDT is breaking out of this multi year base.
* The current weekly close is super strong (if it closes like this)
* no MA resistance on the daily (above 50,100 & 200)
* Above 50 & 100 MAs on Weekly
* IHS breakout on the weekly chart, followed by a flag and retest of support zone
I am currently
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MDT4099940
Medtronic, Inc. 4.625% 15-MAR-2044Yield to maturity
5.71%
Maturity date
Mar 15, 2044
MDTA
Medtronic, Inc. 4.0% 01-APR-2043Yield to maturity
5.45%
Maturity date
Apr 1, 2043
MDT3831466
Medtronic, Inc. 4.5% 15-MAR-2042Yield to maturity
5.37%
Maturity date
Mar 15, 2042
MDT4284342
Medtronic, Inc. 4.625% 15-MAR-2045Yield to maturity
5.30%
Maturity date
Mar 15, 2045
MDT.GM
Medtronic, Inc. 6.5% 15-MAR-2039Yield to maturity
5.25%
Maturity date
Mar 15, 2039
MDT.GO
Medtronic, Inc. 5.55% 15-MAR-2040Yield to maturity
5.19%
Maturity date
Mar 15, 2040
MDT3673737
Covidien International Finance SA 6.55% 15-OCT-2037Yield to maturity
5.12%
Maturity date
Oct 15, 2037
XS283436845
Medtronic, Inc. 4.15% 15-OCT-2053Yield to maturity
4.64%
Maturity date
Oct 15, 2053
XS223879268
Medtronic Global Holdings S.C.A. 1.625% 15-OCT-2050Yield to maturity
4.55%
Maturity date
Oct 15, 2050
MDT4284341
Medtronic, Inc. 4.375% 15-MAR-2035Yield to maturity
4.55%
Maturity date
Mar 15, 2035
XS202067115
Medtronic Global Holdings S.C.A. 1.75% 02-JUL-2049Yield to maturity
4.54%
Maturity date
Jul 2, 2049
See all MDT bonds









